Where is Magenta Therapeutics headquartered?

Magenta Therapeutics is located in Cambridge, MA.

Who invested in Magenta Therapeutics?

Magenta Therapeutics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Magenta Therapeutics raised to date?

Magenta Therapeutics has raised ____.

When was the last funding round for Magenta Therapeutics?

Magenta Therapeutics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

magentatx.com

Magenta Therapeutics

Magenta researches, develops and commercializes hematopoietic stem cell transplants for the treatment of immune and blood-based diseases.

Business Model:

Revenue: $0

Employees: 51-200

Geographic Data

Address: 50 Hampshire Street

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$86M

Raised Total:

$220M

Social

Twitter

Crunchbase

Metrics

2,494,237Website Global Rank

7,235Website Monthly Traffic

Twitter Followers

Description

Magenta researches, develops and commercializes hematopoietic stem cell transplants for the treatment of immune and blood-based diseases.

Contact Phone:
+18572420170

Contact Email:

IPO Details

Magenta Therapeutics went public on 6/20/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/20/2018

IPO Valuation:
$515M

Ticker Symbol:
MGTA

IPO Price:
$15/share

Amount Raised:
$100M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
4/2017	Series B		$50M	Google Ventures Atlas Venture Third Rock Ventures Access Industries Casdin Capital
4/2018	Series C		$0	Be The Match BioTherapies The Watermill Group Access Industries Casdin Capital EcoR1 Capital Casdin Capital Eventide Be The Match BioTherapies The Watermill Group Access Industries Casdin Capital EcoR1 Capital Casdin Capital Eventide
11/2016	Series A		$17.7M	Third Rock Ventures Atlas Venture
6/2018	IPO		$100M
11/2016	Series A	2	$48.5M	Atlas Venture Third Rock Ventures Atlas Venture Third Rock Ventures
5/2017	Series B		$0	GV Access Industries Atlas Venture Be The Match BioTherapies Casdin Capital Partners Innovation Fund Third Rock Ventures GV Access Industries Atlas Venture Be The Match BioTherapies Casdin Capital Partners Innovation Fund Third Rock Ventures
5/2021	Post-IPO Equity	5	$86.4M	Deep Track Capital Great Point Partners Janus Henderson Investors OrbiMed TCG Crossover Deep Track Capital Great Point Partners Janus Henderson Investors OrbiMed TCG Crossover
6/2020	Post-IPO Equity		$69M
4/2018	Series C	6	$52M	Casdin Capital, LLC EcoR1 Capital Eventide Asset Management Be the Match BioTherapies Access Industries Be The Match BioTherapies The Watermill Group Access Industries Casdin Capital EcoR1 Capital Casdin Capital
5/2017	Series B	7	$50M	GV GV

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details